J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 84 (2003), 1215-1221; DOI 10.1099/vir.0.18974-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buttinelli, G.
Right arrow Articles by Fiore, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buttinelli, G.
Right arrow Articles by Fiore, L.
Agricola
Right arrow Articles by Buttinelli, G.
Right arrow Articles by Fiore, L.
© 2003 Society for General Microbiology

Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis

Gabriele Buttinelli1, Valentina Donati1, Stefano Fiore1, Jill Marturano1, Alessandro Plebani2, Paolo Balestri3, Anna Rosa Soresina2, Rossella Vivarelli3, Francis Delpeyroux4, Javier Martin5 and Lucia Fiore1

1 Laboratory of Virology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
2 Department of Pediatrics, University of Brescia, Italy
3 Pediatrics Unit, University of Siena, Italy
4 Epidemiologie Moleculaire des Enterovirus, Institut Pasteur, Paris, France
5 NIBSC, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK

Correspondence
Lucia Fiore
fiore{at}iss.it

The molecular and antigenic properties of a Sabin-like type 2 poliovirus, isolated from the stool samples of a 2-year-old agammaglobulinaemic child who developed paralysis 1 year after receiving the third dose of oral poliovirus vaccine, were analysed. The virus revealed 0·88 % genome variation in the VP1 region compared with the standard reference strain, compatible with replication of the virus in the intestine over approximately 1 year. The typical mutations in the 5'NCR and VP1 associated with reversion to neurovirulence for Sabin type 2 poliovirus were found. Despite this, the virus was characterized by both PCR and ELISA tests as Sabin-like and showed temperature sensitivity and neurovirulence in transgenic mice typical of the Sabin type 2 vaccine strain. Gammaglobulin replacement therapy led rapidly to virus clearance, which, when combined with treatment with the antiviral drug pleconaril, stopped virus excretion; no further virus shedding occurred. This is the first case of poliomyelitis and long-term excretion from an immunodeficient patient to be reported in Italy through the active ‘Acute Flaccid Paralysis' surveillance system.




This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
S. Zurbriggen, K. Tobler, C. Abril, S. Diedrich, M. Ackermann, M. A. Pallansch, and A. Metzler
Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine
Appl. Envir. Microbiol., September 15, 2008; 74(18): 5608 - 5614.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
E. Dedepsidis, Z. Kyriakopoulou, V. Pliaka, C. Kottaridi, E. Bolanaki, S. Levidiotou-Stefanou, D. Komiotis, and P. Markoulatos
Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece
Appl. Envir. Microbiol., November 1, 2007; 73(21): 6697 - 6704.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-F. Yang, H.-Y. Chen, J. Jorba, H.-C. Sun, S.-J. Yang, H.-C. Lee, Y.-C. Huang, T.-Y. Lin, P.-J. Chen, H. Shimizu, et al.
Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient
J. Virol., October 15, 2005; 79(20): 12623 - 12634.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. A. Cherkasova, M. L. Yakovenko, G. V. Rezapkin, E. A. Korotkova, O. E. Ivanova, T. P. Eremeeva, L. I. Krasnoproshina, N. I. Romanenkova, N. R. Rozaeva, L. Sirota, et al.
Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine
J. Virol., January 15, 2005; 79(2): 1062 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Martin, K. Odoom, G. Tuite, G. Dunn, N. Hopewell, G. Cooper, C. Fitzharris, K. Butler, W. W. Hall, and P. D. Minor
Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child
J. Virol., December 15, 2004; 78(24): 13839 - 13847.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Blomqvist, C. Savolainen, P. Laine, P. Hirttio, E. Lamminsalo, E. Penttila, S. Joks, M. Roivainen, and T. Hovi
Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia
J. Virol., May 1, 2004; 78(9): 4876 - 4883.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. A. Korotkova, R. Park, E. A. Cherkasova, G. Y. Lipskaya, K. M. Chumakov, E. V. Feldman, O. M. Kew, and V. I. Agol
Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future
J. Virol., December 1, 2003; 77(23): 12460 - 12465.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2003 by the Society for General Microbiology.